2023-04-26 03:17:15 ET
- Novozymes A/S press release ( OTCPK:NVZMF ): Q1 GAAP EPS of DKK 2.82.
- Revenue of DKK 4.62B (+5.7% Y/Y), delivers 5% organic sales growth, an EBIT-margin of 26.0% before special items, and ROIC including goodwill of 17.7% before special items.
- 2023 outlook maintained: Solid organic sales growth outlook maintained at 4-7% driven by pricing as well as volume growth. Pricing is expected to contribute more than half of the organic sales growth.
- EBIT margin before special items is expected at 25-26%. ROIC incl. goodwill before special items at 16-17%.
For further details see:
Novozymes A/S GAAP EPS of DKK2.82, revenue of DKK4.62B; reaffirms FY22 guidance